Controversial drug approval stirs deep concerns—and hope
In September, the Food and Drug Administration approved Exondys, a controversial treatment for Duchenne muscular dystrophy based on tenuous data from just 12 patients. The cover story in Chemical & Engineering News (C&EN), ...
Nov 16, 2016
0
1